Compare NOM & HBIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | NOM | HBIO |
|---|---|---|
| Founded | 1993 | 1901 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Investment Managers | Biotechnology: Laboratory Analytical Instruments |
| Sector | Finance | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 26.7M | 22.1M |
| IPO Year | N/A | 2000 |
| Metric | NOM | HBIO |
|---|---|---|
| Price | $10.58 | $0.59 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 3 |
| Target Price | N/A | ★ $2.50 |
| AVG Volume (30 Days) | 9.3K | ★ 411.9K |
| Earning Date | 01-01-0001 | 05-13-2026 |
| Dividend Yield | ★ 3.39% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $116,176,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $7.80 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $9.63 | $0.28 |
| 52 Week High | $12.19 | $0.95 |
| Indicator | NOM | HBIO |
|---|---|---|
| Relative Strength Index (RSI) | 36.74 | 52.75 |
| Support Level | $10.30 | $0.41 |
| Resistance Level | $10.95 | $0.64 |
| Average True Range (ATR) | 0.28 | 0.04 |
| MACD | -0.06 | 0.01 |
| Stochastic Oscillator | 14.52 | 64.35 |
Nuveen Missouri Quality Municipal Income Fund is a diversified, closed-end management investment company operating in the United States. The Fund's investment objective is current income exempt from both regular federal income taxes and Missouri personal income taxes, and to enhance portfolio value relative to the Missouri municipal bond market by investing in tax-exempt Missouri municipal obligations that are underrated or undervalued or that represent municipal market sectors that are undervalued. The fund invests in municipal securities as well as floating rate securities, and derivatives such as futures, options, and swap contracts to the necessary extent.
Harvard Bioscience Inc is a developer, manufacturer, and seller of technologies, specialized products and services that enable fundamental research, pharmaceutical and therapy discovery, bioproduction, and pre-clinical testing for drug development. Its primary focus is scientific instruments used to advance life sciences and research. With operations in North America, Europe and china it sells through a combination of direct and distribution channels to customers around the world. The product brands of the company include Harvard Apparatus, DSI, Buxco, Biochrom, BTX, Heka, Hugo Sachs, and Panlab. The majority of its revenue comes from the United States.